Deferred Tax Assets, Valuation Allowance of CHAMPIONS ONCOLOGY, INC. from 30 Apr 2012 to 30 Apr 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
CHAMPIONS ONCOLOGY, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Apr 2012 to 30 Apr 2025.
  • CHAMPIONS ONCOLOGY, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Apr 2025 was $14,838,000, a 18% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

CHAMPIONS ONCOLOGY, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $14,838,000 -$3,268,000 -18% 30 Apr 2025 10-K 23 Jul 2025 2025 FY
Q1 2024 $18,106,000 +$1,350,000 +8.1% 30 Apr 2024 10-K 23 Jul 2025 2025 FY
Q1 2023 $16,756,000 +$1,254,000 +8.1% 30 Apr 2023 10-K 19 Jul 2024 2024 FY
Q1 2022 $15,502,000 +$161,000 +1% 30 Apr 2022 10-K 24 Jul 2023 2023 FY
Q1 2021 $15,341,000 -$119,000 -0.77% 30 Apr 2021 10-K 22 Jul 2022 2022 FY
Q1 2020 $15,460,000 +$507,000 +3.4% 30 Apr 2020 10-K 26 Jul 2021 2021 FY
Q1 2019 $14,953,000 +$544,000 +3.8% 30 Apr 2019 10-K 28 Jul 2020 2020 FY
Q1 2018 $14,409,000 -$7,370,000 -34% 30 Apr 2018 10-K 29 Jul 2019 2019 FY
Q1 2017 $21,779,000 +$2,708,000 +14% 30 Apr 2017 10-K 30 Jul 2018 2018 FY
Q1 2016 $19,071,000 +$3,859,000 +25% 30 Apr 2016 10-K 28 Jul 2017 2017 FY
Q1 2015 $15,212,000 +$4,244,000 +39% 30 Apr 2015 10-K 29 Jul 2016 2016 FY
Q1 2014 $10,968,000 +$2,020,000 +23% 30 Apr 2014 10-K 29 Jul 2015 2015 FY
Q1 2013 $8,948,000 +$2,575,000 +40% 30 Apr 2013 10-K 28 Jul 2014 2014 FY
Q1 2012 $6,373,000 30 Apr 2012 10-K 26 Jul 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.